Wachtell, Paul Weiss Advise On Pfizer's $7.3B Obesity Path
By Al Barbarino · September 22, 2025, 4:06 PM EDT
Pfizer Inc. will acquire Metsera Inc. for $4.9 billion in cash, as the U.S. pharmaceutical giant bets on the biotech firm's experimental treatments for obesity and cardiometabolic diseases, the companies said...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login